Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …

Thyroid cancer is the most common endocrine malignancy giving rise to one of the most
indolent solid cancers, but also one of the most lethal. In recent years, systematic studies of …

There is now a reasonably good understanding of the key oncogenic events involved in the
initiation and progression of thyroid cancer. Many of these are characteristic of certain tumor …

Thyroid cancer is the most common endocrine malignancy; it accounts for approximately 1%
of all new case of cancer each year, and its incidence has increased significantly over the …

The incidence of thyroid cancer (TC) has increased worldwide over the past four decades.
TC is divided into three main histological types: differentiated (papillary and follicular TC) …

Thyroid cancer, a cancerous tumor or growth located within the thyroid gland, is the most
common endocrine cancer. It is one of the few cancers whereby incidence rates have …

Tumors of thyroid follicular cells provide a very interesting model to understand the
development of human cancer. It is becoming apparent that distinct molecular events are …

Thyroid cancer is the most common malignancy of the endocrine system, and its incidence
has been steadily increasing. Advances in sequencing have allowed analysis of the entire …

This review describes the gene expression profile changes associated with the presence of
different mutations that contribute to thyroid cell carcinogenesis. The results are discussed in …

Several previous studies have shown that mutations in B‑Raf proto‑oncogene (BRAF) and
telomerase reverse transcriptase (TERT) can be used for the diagnosis and prognosis of …